2025 Q3 -tulosraportti
80 päivää sitten23 min
Tarjoustasot
Nasdaq Copenhagen
Määrä
Osto
31 698
Myynti
Määrä
24 411
Viimeisimmät kaupat
| Aika | Hinta | Määrä | Ostaja | Myyjä |
|---|---|---|---|---|
| 2 713 | - | - | ||
| 6 698 | - | - | ||
| 2 819 | - | - | ||
| 12 181 | - | - | ||
| 390 | - | - |
Ylin
0,985VWAP
Alin
0,945VaihtoMäärä
0,3 274 195
VWAP
Ylin
0,985Alin
0,945VaihtoMäärä
0,3 274 195
Välittäjätilasto
Dataa ei löytynyt
Yhtiötapahtumat
Datan lähde: FactSet, Quartr| Seuraava tapahtuma | |
|---|---|
| 2025 Q4 -tulosraportti | 26.3. |
| Menneet tapahtumat | ||
|---|---|---|
| 2025 Q3 -tulosraportti | 19.11.2025 | |
| 2025 Q2 -tulosraportti | 15.8.2025 | |
| 2025 Q1 -tulosraportti | 8.5.2025 | |
| 2024 Q4 -tulosraportti | 20.3.2025 | |
| 2024 Q3 -tulosraportti | 14.11.2024 |
Asiakkaat katsoivat myös
Shareville
Liity keskusteluun SharevillessäShareville on aktiivisten yksityissijoittajien yhteisö, jossa voit seurata muiden asiakkaiden kaupankäyntiä ja omistuksia.
Kirjaudu
·1 päivä sittenWatch or rewatch webinar regarding preliminary financial statements Q4 2025 https://www.inderes.dk/videos/bioporto-praesentation-af-forelobige-2025-resultater-samt-2026-guidance
·1 päivä sittenI have a position now. What happens "next"? = Target price... Latest kr. 4,- that was withdrawn... What will be next?..·18 t sittenRecalls the time leading up to SAS being delisted, where 3D with great wisdom, could reassure all his co-investors that SAS was a good business and one just had to be patient 😅 Does he live in a parallel universe?·9 t sittenIt's quite typical. When a certain type of small investors has first bought a stock, they remain positive, simply because they own it, regardless of what disasters happen along the way. I mention Brain+ again, where there's an entire cheerleading squad that can endlessly and unconsciously list the same hopeless arguments for buying, as they have done in the past year, during which the stock has fallen 99.99%. And they are still convinced that those arguments will secure them infinite wealth, even now that the company has been sent into reconstruction. Patience is good, especially in stock trading. But when patience rather covers being inflexible and not being ready to change one's mind with ongoing developments, then it costs dearly, even mega dearly, as one can see in both bioporto and Brain+ and SAS by the way.- ·1 päivä sittenRUO revenue saves the financial report, now that hospitals refrain from buying the product. Remarkable development. 3D otherwise talked a lot about the "recurring orders" that would secure the future, but apparently it's only sales to research that drives limited growth. I don't think 3D comments on this development, but I think others should be aware that management itself "notes" the RUO revenue and it cannot be equated with normal revenue. It embellishes the result, but also reveals a business that is declining more than the headline reveals when the "strong" momentum is described by management.·1 päivä sittenThat RUO still takes up so much space and further confirms that there is no significant and real growth. The optimists are lying to themselves. And as BP communicates, they almost seem to deliberately feed those lies. I am now becoming more and more concerned about BP because there is so little real demand for ngal. And where I long believed that a day would surely come when the optimists would send the stock on one of the sudden upturns it has taken before, I now believe less and less in that possibility. I mostly believe in a slow painful death
- ·1 päivä sitten · MuokattuJust 300.000 kr from a result below guidance. Revenue increases by 11 % in 2025 and the EBIT loss increases by approx. 8 %. Should BP really bet on a new market in India @3D now that BP is riding the big wave? Expects a growth of +20 % in 2026 and again BP tries with an assessment that growth will only come late in 2026. Wasn't it the same old story from 2025, where growth didn't materialize and it resulted in 2 downgrades instead. The cash reserves show that there is operation for approx. 7-8 months from January 1, 2026, until the cash reserves need to be refilled again. The clock is ticking.
- ·1 päivä sitten · MuokattuThere is a webcast at 2 PM today, regarding the financial report that was released yesterday. Registration required. https://hca.videosync.fi/2026-02-06-investor-prsentation/register
Yllä olevat kommentit ovat peräisin Nordnetin sosiaalisen verkoston Sharevillen käyttäjiltä, eikä niitä ole muokattu eikä Nordnet ole tarkastanut niitä etukäteen. Ne eivät tarkoita, että Nordnet tarjoaisi sijoitusneuvoja tai sijoitussuosituksia. Nordnet ei ota vastuuta kommenteista.
Uutiset
Tämän sivun uutiset ja/tai sijoitussuositukset tai otteet niistä sekä niihin liittyvät linkit ovat mainitun tahon tuottamia ja toimittamia. Nordnet ei ole osallistunut materiaalin laatimiseen, eikä ole tarkistanut sen sisältöä tai tehnyt sisältöön muutoksia. Lue lisää sijoitussuosituksista.
2025 Q3 -tulosraportti
80 päivää sitten23 min
Uutiset
Tämän sivun uutiset ja/tai sijoitussuositukset tai otteet niistä sekä niihin liittyvät linkit ovat mainitun tahon tuottamia ja toimittamia. Nordnet ei ole osallistunut materiaalin laatimiseen, eikä ole tarkistanut sen sisältöä tai tehnyt sisältöön muutoksia. Lue lisää sijoitussuosituksista.
Shareville
Liity keskusteluun SharevillessäShareville on aktiivisten yksityissijoittajien yhteisö, jossa voit seurata muiden asiakkaiden kaupankäyntiä ja omistuksia.
Kirjaudu
- ·1 päivä sittenWatch or rewatch webinar regarding preliminary financial statements Q4 2025 https://www.inderes.dk/videos/bioporto-praesentation-af-forelobige-2025-resultater-samt-2026-guidance
- ·1 päivä sittenI have a position now. What happens "next"? = Target price... Latest kr. 4,- that was withdrawn... What will be next?..·18 t sittenRecalls the time leading up to SAS being delisted, where 3D with great wisdom, could reassure all his co-investors that SAS was a good business and one just had to be patient 😅 Does he live in a parallel universe?·9 t sittenIt's quite typical. When a certain type of small investors has first bought a stock, they remain positive, simply because they own it, regardless of what disasters happen along the way. I mention Brain+ again, where there's an entire cheerleading squad that can endlessly and unconsciously list the same hopeless arguments for buying, as they have done in the past year, during which the stock has fallen 99.99%. And they are still convinced that those arguments will secure them infinite wealth, even now that the company has been sent into reconstruction. Patience is good, especially in stock trading. But when patience rather covers being inflexible and not being ready to change one's mind with ongoing developments, then it costs dearly, even mega dearly, as one can see in both bioporto and Brain+ and SAS by the way.
- ·1 päivä sittenRUO revenue saves the financial report, now that hospitals refrain from buying the product. Remarkable development. 3D otherwise talked a lot about the "recurring orders" that would secure the future, but apparently it's only sales to research that drives limited growth. I don't think 3D comments on this development, but I think others should be aware that management itself "notes" the RUO revenue and it cannot be equated with normal revenue. It embellishes the result, but also reveals a business that is declining more than the headline reveals when the "strong" momentum is described by management.·1 päivä sittenThat RUO still takes up so much space and further confirms that there is no significant and real growth. The optimists are lying to themselves. And as BP communicates, they almost seem to deliberately feed those lies. I am now becoming more and more concerned about BP because there is so little real demand for ngal. And where I long believed that a day would surely come when the optimists would send the stock on one of the sudden upturns it has taken before, I now believe less and less in that possibility. I mostly believe in a slow painful death
- ·1 päivä sitten · MuokattuJust 300.000 kr from a result below guidance. Revenue increases by 11 % in 2025 and the EBIT loss increases by approx. 8 %. Should BP really bet on a new market in India @3D now that BP is riding the big wave? Expects a growth of +20 % in 2026 and again BP tries with an assessment that growth will only come late in 2026. Wasn't it the same old story from 2025, where growth didn't materialize and it resulted in 2 downgrades instead. The cash reserves show that there is operation for approx. 7-8 months from January 1, 2026, until the cash reserves need to be refilled again. The clock is ticking.
- ·1 päivä sitten · MuokattuThere is a webcast at 2 PM today, regarding the financial report that was released yesterday. Registration required. https://hca.videosync.fi/2026-02-06-investor-prsentation/register
Yllä olevat kommentit ovat peräisin Nordnetin sosiaalisen verkoston Sharevillen käyttäjiltä, eikä niitä ole muokattu eikä Nordnet ole tarkastanut niitä etukäteen. Ne eivät tarkoita, että Nordnet tarjoaisi sijoitusneuvoja tai sijoitussuosituksia. Nordnet ei ota vastuuta kommenteista.
Tarjoustasot
Nasdaq Copenhagen
Määrä
Osto
31 698
Myynti
Määrä
24 411
Viimeisimmät kaupat
| Aika | Hinta | Määrä | Ostaja | Myyjä |
|---|---|---|---|---|
| 2 713 | - | - | ||
| 6 698 | - | - | ||
| 2 819 | - | - | ||
| 12 181 | - | - | ||
| 390 | - | - |
Ylin
0,985VWAP
Alin
0,945VaihtoMäärä
0,3 274 195
VWAP
Ylin
0,985Alin
0,945VaihtoMäärä
0,3 274 195
Välittäjätilasto
Dataa ei löytynyt
Asiakkaat katsoivat myös
Yhtiötapahtumat
Datan lähde: FactSet, Quartr| Seuraava tapahtuma | |
|---|---|
| 2025 Q4 -tulosraportti | 26.3. |
| Menneet tapahtumat | ||
|---|---|---|
| 2025 Q3 -tulosraportti | 19.11.2025 | |
| 2025 Q2 -tulosraportti | 15.8.2025 | |
| 2025 Q1 -tulosraportti | 8.5.2025 | |
| 2024 Q4 -tulosraportti | 20.3.2025 | |
| 2024 Q3 -tulosraportti | 14.11.2024 |
2025 Q3 -tulosraportti
80 päivää sitten23 min
Uutiset
Tämän sivun uutiset ja/tai sijoitussuositukset tai otteet niistä sekä niihin liittyvät linkit ovat mainitun tahon tuottamia ja toimittamia. Nordnet ei ole osallistunut materiaalin laatimiseen, eikä ole tarkistanut sen sisältöä tai tehnyt sisältöön muutoksia. Lue lisää sijoitussuosituksista.
Yhtiötapahtumat
Datan lähde: FactSet, Quartr| Seuraava tapahtuma | |
|---|---|
| 2025 Q4 -tulosraportti | 26.3. |
| Menneet tapahtumat | ||
|---|---|---|
| 2025 Q3 -tulosraportti | 19.11.2025 | |
| 2025 Q2 -tulosraportti | 15.8.2025 | |
| 2025 Q1 -tulosraportti | 8.5.2025 | |
| 2024 Q4 -tulosraportti | 20.3.2025 | |
| 2024 Q3 -tulosraportti | 14.11.2024 |
Shareville
Liity keskusteluun SharevillessäShareville on aktiivisten yksityissijoittajien yhteisö, jossa voit seurata muiden asiakkaiden kaupankäyntiä ja omistuksia.
Kirjaudu
- ·1 päivä sittenWatch or rewatch webinar regarding preliminary financial statements Q4 2025 https://www.inderes.dk/videos/bioporto-praesentation-af-forelobige-2025-resultater-samt-2026-guidance
- ·1 päivä sittenI have a position now. What happens "next"? = Target price... Latest kr. 4,- that was withdrawn... What will be next?..·18 t sittenRecalls the time leading up to SAS being delisted, where 3D with great wisdom, could reassure all his co-investors that SAS was a good business and one just had to be patient 😅 Does he live in a parallel universe?·9 t sittenIt's quite typical. When a certain type of small investors has first bought a stock, they remain positive, simply because they own it, regardless of what disasters happen along the way. I mention Brain+ again, where there's an entire cheerleading squad that can endlessly and unconsciously list the same hopeless arguments for buying, as they have done in the past year, during which the stock has fallen 99.99%. And they are still convinced that those arguments will secure them infinite wealth, even now that the company has been sent into reconstruction. Patience is good, especially in stock trading. But when patience rather covers being inflexible and not being ready to change one's mind with ongoing developments, then it costs dearly, even mega dearly, as one can see in both bioporto and Brain+ and SAS by the way.
- ·1 päivä sittenRUO revenue saves the financial report, now that hospitals refrain from buying the product. Remarkable development. 3D otherwise talked a lot about the "recurring orders" that would secure the future, but apparently it's only sales to research that drives limited growth. I don't think 3D comments on this development, but I think others should be aware that management itself "notes" the RUO revenue and it cannot be equated with normal revenue. It embellishes the result, but also reveals a business that is declining more than the headline reveals when the "strong" momentum is described by management.·1 päivä sittenThat RUO still takes up so much space and further confirms that there is no significant and real growth. The optimists are lying to themselves. And as BP communicates, they almost seem to deliberately feed those lies. I am now becoming more and more concerned about BP because there is so little real demand for ngal. And where I long believed that a day would surely come when the optimists would send the stock on one of the sudden upturns it has taken before, I now believe less and less in that possibility. I mostly believe in a slow painful death
- ·1 päivä sitten · MuokattuJust 300.000 kr from a result below guidance. Revenue increases by 11 % in 2025 and the EBIT loss increases by approx. 8 %. Should BP really bet on a new market in India @3D now that BP is riding the big wave? Expects a growth of +20 % in 2026 and again BP tries with an assessment that growth will only come late in 2026. Wasn't it the same old story from 2025, where growth didn't materialize and it resulted in 2 downgrades instead. The cash reserves show that there is operation for approx. 7-8 months from January 1, 2026, until the cash reserves need to be refilled again. The clock is ticking.
- ·1 päivä sitten · MuokattuThere is a webcast at 2 PM today, regarding the financial report that was released yesterday. Registration required. https://hca.videosync.fi/2026-02-06-investor-prsentation/register
Yllä olevat kommentit ovat peräisin Nordnetin sosiaalisen verkoston Sharevillen käyttäjiltä, eikä niitä ole muokattu eikä Nordnet ole tarkastanut niitä etukäteen. Ne eivät tarkoita, että Nordnet tarjoaisi sijoitusneuvoja tai sijoitussuosituksia. Nordnet ei ota vastuuta kommenteista.
Tarjoustasot
Nasdaq Copenhagen
Määrä
Osto
31 698
Myynti
Määrä
24 411
Viimeisimmät kaupat
| Aika | Hinta | Määrä | Ostaja | Myyjä |
|---|---|---|---|---|
| 2 713 | - | - | ||
| 6 698 | - | - | ||
| 2 819 | - | - | ||
| 12 181 | - | - | ||
| 390 | - | - |
Ylin
0,985VWAP
Alin
0,945VaihtoMäärä
0,3 274 195
VWAP
Ylin
0,985Alin
0,945VaihtoMäärä
0,3 274 195
Välittäjätilasto
Dataa ei löytynyt